Sean Stalfort

Sean Stalfort has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Verrica Pharmaceuticals Inc. and Dova Pharmaceuticals Inc. Between 19 June 2018 and 14 August 2020, the trades on record add up to 7 filings.

The open-market record is one-sided, with 5 purchases worth €425k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2020: 2 purchases and no sales on the market.

Half of the purchases are above €85k and half below. On 5 out of 5 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. After 4 purchases with a full 90-day history, the hit rate stands at 50% and the median 90-day move at +2.1%. This is a record of the past, not a forecast.

On 17 August 2020 came the latest disclosure, an open-market purchase for €85k in Verrica Pharmaceuticals Inc. Publication is fast: at least half of the trades appear on SEC (Form 4) on the same day. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.